Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
 - EconoTimes)
NEW YORK, May 26, 2017 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Span-America Medical Systems, Inc. (“Span-America” or the “Company”) (Nasdaq:SPAN) in the United States District Court for the District of South Carolina pursuant to which Span-America will be acquired by Savaria Corporation (“Parent”) through its wholly owned subsidiary, Savaria (SC), Inc. (“Merger Sub”) (collectively, “Savaria”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Span-America, its Board of Directors (the “Board”), and Savaria.
On May 1, 2017, Span America’s Board caused the Company to enter into an agreement and plan of merger (the “Merger Agreement”) with Savaria. Pursuant to the terms of the Merger Agreement, Savaria commenced a tender offer (the “Tender Offer”) to purchase all of the issued and outstanding shares of Span common stock for $29.00 in cash per share, or approximately $80 million in total consideration (the “Offer Price”). The Tender Offer is set to expire at 5:00 p.m., New York City Time, on Thursday, June 15, 2017.
The Complaint alleges that the Proposed Transaction is the product of a flawed sales process that favored Savaria at the expense of Span’s shareholders. The Complaint also alleges that the Tender Offer price is grossly inadequate and substantially undervalues Span-America, whereby it is below the mean and median implied values based on Net Sales LTM that Baird calculated for Span; represents a 10.7x Enterprise Value/LTM EBITDA multiple, which is below the 16.9x Enterprise Value/LTM EBITDA from Bloomberg using Span’s Standard Industrial Classification (“SIC”) code; and does not account for the “significant synergies” that exist between Span’s and Savaria’s businesses.
If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.
